Fractyl Revenue and Competitors
Estimated Revenue & Valuation
- Fractyl's estimated annual revenue is currently $16.6M per year.
- Fractyl's estimated revenue per employee is $155,000
- Fractyl's total funding is $310.2M.
Employee Data
- Fractyl has 107 Employees.
- Fractyl grew their employee count by -8% last year.
Fractyl's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder and President | Reveal Email/Phone |
2 | Co-Founder and CEO at Fractyl Health | Reveal Email/Phone |
3 | Chief Commercial Officer | Reveal Email/Phone |
4 | VP Manufacturing-Supply Chain-Service | Reveal Email/Phone |
5 | General Counsel and Corporate Secretary | Reveal Email/Phone |
6 | VP, Human Resources | Reveal Email/Phone |
7 | VP Quality Assurance and Regulatory Affairs | Reveal Email/Phone |
8 | VP Clinical and Medical Affairs | Reveal Email/Phone |
9 | VP manufacturing | Reveal Email/Phone |
10 | Senior Director Marketing | Reveal Email/Phone |
Fractyl Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Fractyl?
Fractyl is a biotechnology firm dedicated to addressing metabolic disorders such as obesity and type 2 diabetes. This is accomplished through the development of novel therapies that target the underlying causes of these conditions, as opposed to merely treating their symptoms. Their primary emphasis is on the gastrointestinal tract and pancreas, with the objective of developing therapeutic interventions that rectify the fundamental pathology. Revita, a heat-based technique designed to enhance blood sugar regulation in diabetics, and Rejuva, an early-stage gene therapy platform, are both in their current pipeline. By doing so, they hope to revolutionize the treatment of metabolic diseases from chronic management to possible remedies, thereby saving lives and preventing the spread of these pervasive conditions. Check here for more information on how to align sales and revenue.
keywords:N/A
$310.2M
Total Funding
107
Number of Employees
$16.6M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Fractyl News
Fractyl Health has developed a new technology called duodenal mucosal resurfacing, which can "reset" your gut, leading to improvements in...
Revitalize-2 is the second pivotal study for the Revita DMR® system (Revita®) in Fractyl Health's Revitalize T2D clinical development...
Fractyl Health has raised $100 million in a round co-led by Maverick Capital, M28 Capital and Population Health Partners. Based in the Boston area, the company is a developer of therapeutics for metabolic diseases. It plans to use the funds to advance clinical studies intended to reduce insulin ...
Fractyl Health, a life sciences company dedicated to developing novel therapeutic interventions aimed at reversing the metabolic disease epidemic, today announced the closing of a $100 million Series F financing. The financing was led by new investors Maverick Capital, M28 Capital, and Populatio ...
Premium Taiwania Capital Management Corporation has led a $55 million Series E financing round in Fractyl Laboratories Inc., a life sciences company focused on tackling metabolic diseases, according to an announcement. Continue reading this story with a subscription to DealStreetAsia. Subscri ...
Other Companies in Lexington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $26.8M | 107 | -1% | N/A |
#2 | $19.4M | 108 | 23% | N/A |
#3 | $18.9M | 108 | -18% | N/A |
#4 | $11M | 108 | 5% | N/A |
#5 | $21.9M | 109 | -5% | N/A |